nevirapine

Generic: nevirapine

Labeler: micro labs limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name nevirapine
Generic Name nevirapine
Labeler micro labs limited
Dosage Form TABLET
Routes
ORAL
Active Ingredients

nevirapine 200 mg/1

Manufacturer
Micro Labs Limited

Identifiers & Regulatory

Product NDC 42571-131
Product ID 42571-131_41535937-97d5-fb3f-e063-6294a90afa9e
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203080
Listing Expiration 2026-12-31
Marketing Start 2012-05-22

Pharmacologic Class

Established (EPC)
human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor [epc]
Mechanism of Action
non-nucleoside reverse transcriptase inhibitors [moa] cytochrome p450 3a inducers [moa] cytochrome p450 2b6 inducers [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42571131
Hyphenated Format 42571-131

Supplemental Identifiers

RxCUI
199422
UPC
0342571131609
UNII
99DK7FVK1H
NUI
N0000175463 N0000175460 N0000009948 N0000190118 N0000187064

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nevirapine (source: ndc)
Generic Name nevirapine (source: ndc)
Application Number ANDA203080 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 6 BLISTER PACK in 1 CARTON (42571-131-29) / 10 TABLET in 1 BLISTER PACK
  • 60 TABLET in 1 BOTTLE (42571-131-60)
source: ndc

Packages (2)

42571-131-29 6 BLISTER PACK in 1 CARTON (42571-131-29) / 10 TABLET in 1 BLISTER PACK 42571-131-60 60 TABLET in 1 BOTTLE (42571-131-60)

Ingredients (1)

nevirapine (200 mg/1)

Linked Drug Pages (1)

NEVIRAPINE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "41535937-97d5-fb3f-e063-6294a90afa9e", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "upc": ["0342571131609"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["fbd628db-4076-4fe0-8323-9cc33ae92e42"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (42571-131-29)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "42571-131-29", "marketing_start_date": "20120522"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (42571-131-60)", "package_ndc": "42571-131-60", "marketing_start_date": "20120522"}], "brand_name": "NEVIRAPINE", "product_id": "42571-131_41535937-97d5-fb3f-e063-6294a90afa9e", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "42571-131", "generic_name": "NEVIRAPINE", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NEVIRAPINE", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA203080", "marketing_category": "ANDA", "marketing_start_date": "20120522", "listing_expiration_date": "20261231"}